Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Probiotics Treatment for Depression in Parkinson's Disease
EF 2025-26
Résumé
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, and its global burden is expected to double between 2015 and 2040. While primarily characterized as a movement disorder and usually defined by motor symptoms, people living with PD experience a broad range of non-motor symptoms including worsened mood and gastrointestinal problems at substantially higher rates than the general population. Growing evidence shows that some cases of PD may start in the gut and probiotics (live strains of bacteria safe for consumption and therapeutic to people) could relieve gastrointestinal symptoms and improve gut health. Recent evidence has also shown that probiotic interventions have the potential to decrease symptoms of depression; therefore, further study of probiotic treatment is warranted to investigate its effects on depressive symptoms of people living with PD.
In this study, we will test whether a daily probiotic supplement can improve depressive symptoms and gut health in people with PD. Participants will take either a probiotic or a placebo (a look-alike powder with no live bacteria) for 12 weeks. Throughout the trial, we will measure changes in depression, anxiety, and fatigue, as well as collect stool and blood samples to understand how the probiotic may affect gut and immune function. By combining clinical assessments with analysis of gut bacteria and biological markers, this research will help us understand whether improving gut health can lead to meaningful improvements in mental well-being for people with PD. If successful, this approach could offer a safe and accessible natural health product option to support the emotional well-being of individuals living with PD.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572619
Name
Leung Tsz Chun Matthew
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Probiotics Treatment for Depression in Parkinson's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Anxiety; Blood And Fecal Samples; Bowel Movements And Constipation; Chronic Fatigue; Depression; Gut Microbiome; Inflammatory Markers; Microbial And Molecular Signatures; Parkinson'S Disease; Probiotic Intervention
Abstract
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, and its global burden is expected to double between 2015 and 2040. While primarily characterized as a movement disorder and usually defined by motor symptoms, people living with PD experience a broad range of non-motor symptoms including worsened mood and gastrointestinal problems at substantially higher rates than the general population. Growing evidence shows that some cases of PD may start in the gut and probiotics (live strains of bacteria safe for consumption and therapeutic to people) could relieve gastrointestinal symptoms and improve gut health. Recent evidence has also shown that probiotic interventions have the potential to decrease symptoms of depression; therefore, further study of probiotic treatment is warranted to investigate its effects on depressive symptoms of people living with PD.
In this study, we will test whether a daily probiotic supplement can improve depressive symptoms and gut health in people with PD. Participants will take either a probiotic or a placebo (a look-alike powder with no live bacteria) for 12 weeks. Throughout the trial, we will measure changes in depression, anxiety, and fatigue, as well as collect stool and blood samples to understand how the probiotic may affect gut and immune function. By combining clinical assessments with analysis of gut bacteria and biological markers, this research will help us understand whether improving gut health can lead to meaningful improvements in mental well-being for people with PD. If successful, this approach could offer a safe and accessible natural health product option to support the emotional well-being of individuals living with PD.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leung, Tsz Chun Matthew
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~